Sobczuk, Paweł http://orcid.org/0000-0002-4103-1626
Bątruk, Huber
Wójcik, Paulina
Iwaniak, Krzysztof
Kozak, Katarzyna http://orcid.org/0000-0002-3225-422X
Rutkowski, Piotr http://orcid.org/0000-0002-8920-5429
Article History
Received: 19 April 2022
Accepted: 13 June 2022
First Online: 1 July 2022
Declarations
:
: P.S. has received travel grants from MSD, Roche, Novartis, and Pierre Fabre and honoraria for lectures from Swixx BioPharma and BMS. Non-financial interests: European Society of Medical Oncology—Officer; Polish Society of Clinical Oncology—Member of Board of Directors. K.K. has received honoraria for lectures from BMS, MSD, Novartis, Pfizer, and Pierre Fabre. S.K. has received travel grants from Pierre Fabre. P.R. (Piotr Rutkowski): Personal financial interests: Blueprint Medicines, Advisory Board; BMS, invited speaker, honoraria for lectures, Advisory Board; Merck, Advisory Board; Merck, invited speaker, honoraria for lectures; MSD, Advisory Board; Novartis, invited speaker; Pierre Fabre, invited speaker, honoraria for lectures; Pierre Fabre, Advisory Board; Sanofi, Advisory Board, invited speaker. Institutional interests: BMS, funding, financial interest, research grant for institution; Pfizer, research grant, financial interest, research grant for ISS. Non-financial interests: ASCO, Officer; Polish Society of Surgical Oncology, Member of Board of Directors. H.B., P.W. and K.I. declare no conflict of interest.